Diabetes, Vol 44, Issue 7 783-789, Copyright © 1995 by American Diabetes Association

ARTICLES

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy

FS Nielsen, P Rossing, LE Bang, TL Svendsen, MA Gall, UM Smidt and HH Parving
Steno Diabetes Center, Gentofte, Denmark.

Nondiabetic hypertensive patients lacking the normal nocturnal decline in arterial blood pressure have enhanced cardiovascular complications. Since cardiovascular morbidity and mortality are increased in non-insulin-dependent diabetes mellitus (NIDDM), we performed a prospective cross-sectional case-controlled study comparing the diurnal variation in arterial blood pressure, prevalence of dippers, cardiac autonomic nervous function (beat-to-beat variation during deep breathing), and extracellular fluid volume (51Cr-labeled EDTA) in 55 NIDDM patients with diabetic nephropathy (group 1), 55 NIDDM patients with normoalbuminuria (group 2), and 22 nondiabetic control subjects (group 3). All antihypertensive treatments were withdrawn at least 2 weeks before the study. The nocturnal blood pressure reduction (daytime-to-nighttime)/daytime (mean +/- SE) was impaired in group 1 (6.6 +/- 1.5%) and group 2 (11.1 +/- 1.4%) as compared with group 3 (17.6 +/- 1.7%), and it was impaired in group 1 as compared with group 2 (P < 0.05 for each comparison). The prevalence of dippers (95% confidence interval) was lower in group 1 (42% [29-56]) as compared with group 2 (58% [44-71]; P = 0.08) and group 3 (86% [65-97]; P < 0.001) and in group 2 as compared with group 3 (P < 0.01). Abolished beat-to-beat variation was more prevalent in group 1 (63% [50-76]) as compared with group 2 (15% [7-27]) and with group 3 (5% [0-23]) (P < 0.001). Nocturnal blood pressure reduction was associated with beat-to-beat variation during deep breathing (r = 0.22, P < 0.01). Extracellular fluid volume (mean +/- SE) was higher in group 1 (15.9 +/- 0.5 l/m2) as compared with group 3 (14.1 +/- 0.8 l/m2) (P < 0.05) with group 2 between the two (15.1 +/- 0.4 l/m2).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Kelley, R. P. Light, and R. Agarwal Trended Cosinor Change Model for Analyzing Hemodynamic Rhythm Patterns in Hemodialysis Patients Hypertension, July 1, 2007; 50(1): 143 - 150. [Abstract] [Full Text] [PDF]

				M. Larsen, M. Wang, and B. Sander Overnight Thickness Variation in Diabetic Macular Edema Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2313 - 2316. [Abstract] [Full Text] [PDF]

				K. Rossing, P. K. Christensen, S. Andersen, P. Hovind, H. P. Hansen, and H.-H. Parving Comparative Effects of Irbesartan on Ambulatory and Office Blood Pressure: A substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Diabetes Care, March 1, 2003; 26(3): 569 - 574. [Abstract] [Full Text] [PDF]

				E. Ritz, V. Schwenger, M. Zeier, and I. Rychlik Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1550 - 1554. [Full Text] [PDF]

				C. Hauerslev Foss, E. Vestbo, A. Frøland, H.J. Gjessing, C.E. Mogensen, and E.M. Damsgaard Autonomic Neuropathy in Nondiabetic Offspring of Type 2 Diabetic Subjects Is Associated With Urinary Albumin Excretion Rate and 24-h Ambulatory Blood Pressure: The Fredericia Study Diabetes, March 1, 2001; 50(3): 630 - 636. [Abstract] [Full Text]

				S. T. Azar and A. Birbari Nocturnal Blood Pressure Elevation in Patients with Type 1 Diabetes Receiving Intensive Insulin Therapy Compared with that in Patients Receiving Conventional Insulin Therapy J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3190 - 3193. [Abstract] [Full Text]